Clinical Trials Arena December 22, 2025
The UAE is emerging as a hub for clinical trials with robust infrastructure and regulatory efficiency.
The UAE is quickly advancing its precision medicine and genomics capabilities, establishing itself as a major emerging global clinical trial hub, said Adel Aziziyeh, Head of Clinical Operations at IROS, a UAE-based contract research organisation (CRO) at a recent conference.
Aziziyeh was speaking at the Outsourcing in Clinical Trials (OCT) and Clinical Trial Supply (CTS) Korea 2025 held earlier this month, 2–3 December.
The region’s rapid evolution is the result of long-term national strategies, including UAE Vision 2031 and Saudi Vision 2030, which explicitly prioritise clinical research infrastructure, said Aziziyeh. Across the Gulf region, governments have expanded hospital networks, advanced diagnostic capabilities, trained specialist...







